A new research study from the American College of Lifestyle Medicine provides real-world evidence that deprescribing glucoseālowering medications is both feasible and safe when patients with type 2 diabetes receive lifestyleāinformed care in primary care settings.Read More
New study demonstrates feasibility and safety of deprescribing diabetes medications when lifestyle medicine is integrated into primary care
Related Posts
Add A Comment
